A previous study revealed a beneficial impact of administering L-asparaginase combined with an mTOR inhibitor, temsirolimus, followed by the administration of metformin in four R/R DLBCL patients exhibiting an OxPhos profile (GAPDHlow) [28]. Here, MTOR is linked to diffuse large B-cell lymphoma.